DUBLIN--(BUSINESS WIRE)--The "Graves' Disease Forecast in 23 Major Markets 2017-2027" report has been added to Research and Markets' offering.
Graves' disease is an autoimmune disease of the thyroid gland, in which the thyroid attacked by the body's own defence mechanisms becomes enlarged and produces increased amount of hormones, causing hyperthyroidism. The condition induces signs and symptoms that seriously affect the patient's quality of life, everyday activities and ability to work.
This report provides the current prevalent population for Graves' disease across 23 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, The Netherlands, Norway, Sweden, Austria, Denmark, Iceland, Switzerland, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Graves' disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
The quantified symptoms and co-morbidities for Graves' disease include:
- Graves' Ophthalmopathy
- Acropachy
-
Thyroid dermopathy
Key Topics Covered:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key Comorbid Conditions / Features Associated With the Disease
8. Methodology for Quantification of Patient Numbers
9. Top-Line Prevalence for Graves' Disease
10. Features of Graves' Disease Patients
11. Comorbid Conditions of Graves' Disease Patients
12. Abbreviations Used in the Report
13. Other Publications
14. Patient-Based Databases
15. Patient-Based Offering
16. Online Pricing Data & Platforms
17. References
18. Appendix
For more information about this report visit https://www.researchandmarkets.com/research/w4tvrf/graves_disease
